Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
BOSTON--(BUSINESS WIRE)--
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the grant of 380,500 restricted stock units (RSUs) to 24 new employees and stock options to purchase 50,000 shares of its common stock to one new employee.The awards were granted pursuant to the Nasdaq inducement grant exception as an inducement material to the employee’s acceptance of employment with Verastem Oncology in accordance with Nasdaq Listing Rule 5635(c)(4).
The stock options have an exercise price equal to $7.90, the closing price of Verastem Oncology’s common stock as reported by Nasdaq on October 1, 2026. A total of 380,500 RSUs granted to the 24 new employees and the stock options to purchase 50,000 shares of common stock granted to one new employee will vest at a rate of 25% on the one-year anniversary of each employee’s date of hire, with the remaining shares vesting quarterly over the next three years in equal quarterly amounts, provided the employee is employed by or providing other services for Verastem Oncology on each such vesting date.
About Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) is a biopharmaceutical company committed to developing and commercializing new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Verastem markets AVMAPKI® FAKZYNJA® CO-PACK in the U.S. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition, and KRAS G12D inhibition. For more information, please visit www.verastem.com and follow us on LinkedIn.
For Investor and Media Inquiries:
Julissa Viana
Senior Vice President, Corporate Communications, Investor Relations & Patient Advocacy
investors@verastem.com or
media@verastem.com
Source: Verastem Oncology
Key Terms
restricted stock unitsfinancial
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
nasdaq inducement grant exceptionregulatory
A Nasdaq inducement grant exception is a narrow rule that lets a listed company give stock or options to a newly hired employee without first getting shareholder approval, provided the award meets strict size, timing and disclosure conditions. For investors it matters because such grants can dilute existing shares, signal how the company attracts talent, and affect executive incentives—similar to a signing bonus paid partly in stock instead of cash.
